Reference
NICE. Life-extending breast cancer drug approved by NICE in draft guidance. Internet Document : 3 Nov 2016. Available from: URL: https://www.nice.org.uk/news/article/life-extending-breast-cancer-drug-approved-by-nice-in-draft-guidance
Rights and permissions
About this article
Cite this article
NICE recommends eribulin for advanced breast cancer. PharmacoEcon Outcomes News 766, 36 (2016). https://doi.org/10.1007/s40274-016-3557-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-3557-4